Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Methoxymorpholinyldoxorubicin
It is also active against dermatophytes
Novel medication targets for the treatment of alcoholism: preclinical studies
specifically a selective
FPH1 was suggested to be supplemented into the culture medium on day 1 and 5 at a concentration of 15-20 μM to induce functional proliferation of primary human hepatocytes in vitro
JZL 184 - CAS# 1101854-58-3 oriconazole MethoxymorpholinyldoxorubicinJZL184 is highly selective, and potent MAGL inhibitor ( monoacylglycerol lipase inhibitor). JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome. JZL184 attenuates LPS induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action. JZL184 also suppresses inflammatory pain in the mouse carrageenan model. Product information CAS Number: 1101854 58 3 Molecular Weight: